Yesterday, the head of AstraZeneca said it wouldn't be surprising if levels of protection dip with the South Africa varying, given what we've seen in early results from other vaccines developers already working on tweaking their vaccines to cope with new emerging variants.
昨天,阿斯利康公司的負責人表示,鑑於我們在其他疫苗開發商已經致力於調整其疫苗以應對新出現的變種的早期結果中所看到的情況,如果保護水準與南非不同,這並不令人驚訝。